Canada markets close in 3 hours 42 minutes

Corcept Therapeutics Incorporated (HTD.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
24.82-0.05 (-0.20%)
As of 09:18AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 2.61B
Enterprise Value 2.23B
Trailing P/E 25.53
Forward P/E 37.45
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.65
Price/Book (mrq)5.09
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.50
52-Week Change 313.05%
S&P500 52-Week Change 326.27%
52 Week High 331.60
52 Week Low 319.40
50-Day Moving Average 322.18
200-Day Moving Average 324.61

Share Statistics

Avg Vol (3 month) 317
Avg Vol (10 day) 35
Shares Outstanding 5104.11M
Implied Shares Outstanding 6105M
Float 885.36M
% Held by Insiders 111.38%
% Held by Institutions 186.11%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 22.54%
Operating Margin (ttm)20.09%

Management Effectiveness

Return on Assets (ttm)11.96%
Return on Equity (ttm)21.91%

Income Statement

Revenue (ttm)523.53M
Revenue Per Share (ttm)5.12
Quarterly Revenue Growth (yoy)39.00%
Gross Profit (ttm)N/A
EBITDA 122.8M
Net Income Avi to Common (ttm)117.2M
Diluted EPS (ttm)0.97
Quarterly Earnings Growth (yoy)74.80%

Balance Sheet

Total Cash (mrq)410.76M
Total Cash Per Share (mrq)3.94
Total Debt (mrq)76k
Total Debt/Equity (mrq)0.01%
Current Ratio (mrq)5.18
Book Value Per Share (mrq)5.27

Cash Flow Statement

Operating Cash Flow (ttm)124.84M
Levered Free Cash Flow (ttm)123.86M